Subscribe to unlock this article
Thanks for your support.
Elvio Rossini and Federico Verderi, both SDA Bocconi alumni, have launched B2R Italian Investments, raising €600K to acquire and lead a single high-potential Italian company. Their SF is backed by a mix of Italian and international investors and advisors, including Paolo Guida, Secways, Aniol, Simon Webster, Cabiedes Capital, Pierre Paul Benoit, Victoriam Equity, Linta Partners (Michael Roecker), Marc Bartomeus, Vincenzo Polidoro, John Kenny, Massimiliano D’Amico, Baudouin Lescuyer, Tobias Mohr, João Diogo Stoffel, among others.
The name “B2R” is inspired by Bruce Springsteen’s Born to Run, symbolizing momentum, energy, determination, and the drive to move forward. That same spirit defines B2R’s approach: growing a company over time, step by step, with commitment and consistency. The goal isn’t a quick turnaround, but to build something solid and lasting, working closely with people, valuing what already exists, and helping the business evolve without losing its identity.
With complementary backgrounds across pharma, finance, and entrepreneurship, the two principals bring hands-on, owner-operator capabilities designed to accelerate growth while preserving the culture and strengths of the acquired business. Rossini holds an MBA from SDA Bocconi and has experience in the pharmaceutical market, real-estate entrepreneurship, and commercial due diligence. Verderi, also an SDA Bocconi MBA, brings a track record in M&A, financial analysis, and strategic planning and management consulting, developed through his work alongside Italian SMEs.
Based between Milan and Parma, B2R is seeking one Italian SME with solid fundamentals and room for strategic expansion, particularly in fragmented B2B niches. Screening criteria include revenues of at least €8M, EBITDA of €1.5–4M, positive cash flows over the last three years, meaningful recurring or contracted revenues, and tangible competitive advantages.
Legal: Pedersoli Gattai
